Form 8-K - Current report:
SEC Accession No. 0000950170-25-092318
Filing Date
2025-07-01
Accepted
2025-07-01 17:05:48
Documents
10
Period of Report
2025-07-01
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K apvo-20250701.htm   iXBRL 8-K 40437
  Complete submission text file 0000950170-25-092318.txt   145180

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT apvo-20250701.xsd EX-101.SCH 24892
12 EXTRACTED XBRL INSTANCE DOCUMENT apvo-20250701_htm.xml XML 4697
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37746 | Film No.: 251097329
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)